Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition
Journal of the American Heart Association, 2024
Kraaijenhof J., Cronjé H., Hovingh G., Nurmohamed N., Gill D., Zagkos L.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
CVD | Pathophysiology | Plasma |  Olink Explore 3072/384 |
Abstract
n/a